Viridian Therapeutics Inc (STU:1S1)
€ 19.9 -0.30 (-1.49%) Market Cap: 2.26 Bil Enterprise Value: 1.71 Bil PE Ratio: 0 PB Ratio: 4.42 GF Score: 52/100

Viridian Therapeutics Inc (STU:1S1) Transcripts

  • 1